Session 2 - Allergens and treatment of asthma, rhinitis and atopic dermatitis
March 22, 2022
7:30-10:00 am CST
Intro & Welcome
Lars Poulsen, PhD
7:30-7:45 am
IL-13, periostin and DPP-4 reveal endotype-phenotype associations in patients with atopic dermatitis
Laura Maintz
Abstract #33
7:45-8:00 am
Negative allosteric modulators of the Calcium Sensing Receptor (Calcilytics) abrogate airways and lung interstitial remodelling in asthma
Christopher J. Corrigan
Abstract #15
8:00-8:15 am
Unexpected echo of the airway epithelium after allergen-specific immunotherapy
Constanze A. Jakwerth
Abstract #39
8:15-8:30 am
Grass Pollen Sublingual Immunotherapy drives the generation of functional IL-10-producing Innate Lymphoid Cells that are associated with clinical benefit: A RDBPC Study
Mohamed H. Shamji
Abstract #56
8:30-8:40 am
BREAK
8:40-9:00 am
Improved diagnosis of asthma: Metabolomic profiling of urine AND Improved diagnosis of asthma and COPD: Metabolomic profiling of urine
Darryl Adamko
Abstract #21
9:00-9:15 am
The OM-85 bacterial lysate stabilizes the airway epithelial cell barrier through profound transcriptional and functional effects
Donata Vercelli, MD
Abstract #35
9:15-9:30 am
Staphylococcus aureus Disruption of Keratinocytes in Atopic Dermatitis
Anne Marie Singh, MD
Abstract #18
9:30-9:45 am
Alanine scanning of the unstructured region of Ara h 2 and of a related mimotope reveals those amino acids that are critical for IgE binding
Stephen Dreskin, MD PhD
Abstract #29
9:45 am
Closing Remarks
Lars Poulsen, PhD
|